Observational studyScientific reports2025
Diagnostic value of flow cytometric urine analysis in urinary tract infections of newborns and infants.
Observational study in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This study aimed to compare the results of flow cytometric urine analysis and urine culture for the rapid diagnosis of urinary tract infections and to determine the leukocyte and bacterial cutoffs that could achieve maximum sensitivity and negative predictive value (NPV) during the newborn and infant periods. This cross-sectional observational study included urine samples submitted for culture from the neonatal intensive care unit and outpatient clinic between April 2019 and December 2021. The urine samples were first inoculated for culture and then analyzed for leukocyte and bacterial counts using a flow cytometric method (Sysmex UF-1000i, Kobe, Japan). Maximum sensitivity and NPV values were determined by examining different bacterial and leukocyte cut-offs with Sysmex UF1000i. A total of 138 urine samples from 103 patients were included in the study. The reasons for urine examinations were prolonged hyperbilirubinemia, sepsis, and insufficient weight gain. Although no association was observed with leukocyte count, a bacterial cut-off of 83.4/µL was identified as the optimal threshold. Diagnostic values, including sensitivity (91.6%), specificity (88.6%), NPV (98.5%), and positive predictive value (PPV) (55%), were satisfactory. Based on current data, we suggest that the Sysmex UF-1000i is a valuable screening tool for detecting UTIs in asymptomatic newborns. Integrating this technology into clinical practice could enhance early diagnosis and treatment, ultimately improving neonatal care outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.